share_log

Chardan Capital Maintains Buy on Axcella Health, Lowers Price Target to $5

Chardan Capital Maintains Buy on Axcella Health, Lowers Price Target to $5

Chardan Capital维持对Axcella Health的买入,将目标股价下调至5美元
Benzinga Real-time News ·  2022/11/02 10:36

Chardan Capital analyst Keay Nakae maintains Axcella Health (NASDAQ:AXLA) with a Buy and lowers the price target from $7 to $5.

Chardan Capital分析师Keay Nakae维持Axcella Health(纳斯达克股票代码:AXLA)的买入,并将目标股价从7美元下调至5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发